Search Within

Rona Denit Yaeger

Formats
  1. Meeting Abstract (166)
  2. Journal Article (143)
  3. Review (7)
  4. Editorial (6)
  5. Research Letter (4)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (329)
  2. Gastrointestinal Oncology Service (329)
  3. Solid Tumor Oncology Division (329)
  4. Center for Pancreatic Cancer Research (136)
  5. GSK Faculty (134)
  6. Department of Pathology and Laboratory Medicine (125)

More Groups

People
  1. Andrea Cercek Hanjis (95)
  2. Leonard Saltz (81)
  3. Jinru Shia (76)
  4. Martin Weiser (64)
  5. Zsofia Stadler (62)
  6. Julio Garcia Aguilar (61)

More People

Years
  1. 2025 (29)
  2. 2024 (41)
  3. 2023 (37)
  4. 2022 (39)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Annals of Oncology (37)
  3. Clinical Cancer Research (17)
  4. Cancer Research (15)
  5. Cancer Discovery (14)
  6. Nature Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (111)
  2. American Association for Cancer Research (51)
  3. Oxford University Press (48)
  4. Nature Publishing Group (26)
  5. Elsevier Inc. (19)
  6. Springer (10)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Heterogeneity in microsatellite instability in metastatic colorectal cancer: Mechanisms and clinical implications
    Editorial

    Yaeger, R.
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAPK pathway activation
    Research Letter

    Cocco, E.; Schram, A. M.; Kulick, A.; Misale, S.; Won, H. H.; Yaeger, R.; Razavi, P.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Changes in the multidisciplinary management of rectal cancer from 2009 to 2015 and associated improvements in short-term outcomes
    Journal Article

    Roxburgh, C. S. D.; Strombom, P.; Lynn, P.; Cercek, A.; Gonen, M.; Smith, J. J.; Temple, L. K. F.; Nash, G. M.; Guillem, J. G.; Paty, P. B.; more...
    Colorectal Disease (2019)

    Fulltext@MSK | Save
  • V211D mutation in MEK1 causes resistance to MEK inhibitors in colon cancer
    Journal Article

    Gao, Y.; Maria, A.; Na, N.; da Cruz Paula, A.; Gorelick, A. N.; Hechtman, J. F.; Carson, J.; Lefkowitz, R. A.; Weigelt, B.; Taylor, B. S.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Perianal goblet cell carcinoid with pagetoid spread
    Journal Article

    Grunes, D.; Kim, M. K.; Chessin, D. B.; Yaeger, R. D.; Ward, S. C.
    International Journal of Surgical Pathology (2019)

    Fulltext@MSK | Save
  • ANCHOR CRC: A phase 2, open-label, single arm, multicenter study of encorafenib (ENCO), binimetinib (BIM), plus cetuximab (CETUX) in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Grothey, A.; Yaeger, R.; Paez, D.; Tabernero, J.; Taïeb, J.; Yoshino, T.; Groc, M.; Vedovato, J.; Chetaille, E.; Van Cutsem, E.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • BEACON CRC: A randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer
    Meeting Abstract

    Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H.; Yoshino, T.; Desai, J.; Ciardiello, F.; Gollerkeri, F.; Maharry, K.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion–positive intrahepatic cholangiocarcinoma
    Journal Article

    Goyal, L.; Shi, L.; Liu, L. Y.; Fece de la Cruz, F.; Lennerz, J. K.; Raghavan, S.; Leschiner, I.; Elagina, L.; Siravegna, G.; Ng, R. W. S.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition
    Journal Article

    Allen, A.; Qin, A. C. R.; Raj, N.; Wang, J.; Uddin, S.; Yao, Z.; Tang, L.; Meyers, P. A.; Taylor, B. S.; Berger, M. F.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Binimetinib, encorafenib, and cetuximab triplet therapy for patients with BRAF V600E-mutant metastatic colorectal cancer: Safety lead-in results from the phase III BEACON Colorectal Cancer study
    Journal Article

    Van Cutsem, E.; Huijberts, S.; Grothey, A.; Yaeger, R.; Cuyle, P. J.; Elez, E.; Fakih, M.; Montagut, C.; Peeters, M.; Yoshino, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save